Gastroparesis Drugs Market Anticipated to Reach US$ 6,662.35 Million, with a CAGR of 4.4% from 2024 to 2032
According to Polaris Market Research's latest market analysis, "Gastroparesis Drugs Market by Drug Class (Prokinetic Agents, Antiemetic Agents, and Botulinum Toxin Injections), Disease Class, End User, Region-Global Forecast to 2032," the market size for gastroparesis drugs is expected to increase from USD 4,529.75 million in 2023 to USD 6,662.35 million by 2032, exhibiting a CAGR of 4.4% from 2024 to 2032.The disorder known as gastroparesis harms your stomach's muscles' natural, spontaneous motility. Powerful muscle contractions usually move food through your digestive system.
However, gastroparesis prevents your stomach from emptying properly because it slows down or stops working altogether. In addition to impairing regular digestion, gastroparesis can result in vomiting, nausea, and pain in the abdomen. Nutritional issues and blood sugar issues may also result from it. Medication and dietary modifications can help some people feel better.
๐๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐จ๐ ๐ญ๐ก๐ ๐๐๐ฉ๐จ๐ซ๐ญ: @ https://www.polarismarketresearch.com/industry-analysis/gastroparesis-drugs-market/request-for-sample
Prominent Participants
The research study contains information about market companies and thorough analyses of the competitive landscape of the industry, such as:
๐๐ฒ๐ ๐ง๐ฎ๐ธ๐ฒ๐ฎ๐๐ฎ๐๐
โ The need for gastroparesis medications is being driven primarily by two factors: the sharp rise in the number of surgical procedures that resulted in an increased incidence of post-surgical gastroparesis and the rapid global increase in the prevalence of idiopathic gastroparesis.
โ In 2023, North America dominated the gastroparesis drugs market.
โ Europe is expected to grow at a quick rate during the forecast period.
๐ง๐ต๐ฒ ๐ ๐ฎ๐ท๐ผ๐ฟ ๐ฃ๐น๐ฎ๐๐ฒ๐ฟ๐ ๐ข๐ฝ๐ฒ๐ฟ๐ฎ๐๐ถ๐ป๐ด ๐๐ป ๐ง๐ต๐ฒ ๐๐ป๐ฑ๐๐๐๐ฟ๐ ๐๐ฟ๐ฒ:
โข Abbott Laboratories (US)
โข AbbVie Inc. (US)
โข Allergan Inc. (US)
โข Evoke Pharma (US)
โข Medtronic Plc (Ireland)
โข Neurogastrx Inc. (US)
โข Pfizer Inc. (US)
โข Rhythm Pharmaceuticals Inc. (US)
โข Salix Pharmaceuticals (US)
โข TEVA Pharmaceutical (Israel)
โข Vanda Pharmaceuticals Inc. (US)
๐๐ฎ๐ฒ ๐ญ๐ก๐ข๐ฌ ๐๐ซ๐๐ฆ๐ข๐ฎ๐ฆ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐๐ฉ๐จ๐ซ๐ญ: @ https://www.polarismarketresearch.com/buy/3710/2
๐ ๐ฎ๐ฟ๐ธ๐ฒ๐ ๐ฆ๐ฒ๐ด๐บ๐ฒ๐ป๐๐ฎ๐๐ถ๐ผ๐ป
According to insights on pharmacological classes, the prokinetic agents segment held the highest share in 2023. Segment's popularity is ascribed to its extensive application, which enhances stomach motility and increases stomach muscular contractions. Furthermore, the pharmacy segment is expected to develop at the fastest rate, according to end-user insights. The growth of this sector can be attributed to several factors, including patients' ease of access to pharmacies for the purchase of medications related to gastroparesis and other related treatments, the ongoing expansion of retail pharmacy chains, and their emphasis on developing an online presence.
๐๐ฎ๐๐๐ฟ๐ผ๐ฝ๐ฎ๐ฟ๐ฒ๐๐ถ๐ ๐๐ฟ๐๐ด๐ ๐ ๐ฎ๐ฟ๐ธ๐ฒ๐ ๐ฅ๐ฒ๐ฝ๐ผ๐ฟ๐ ๐๐ถ๐ด๐ต๐น๐ถ๐ด๐ต๐๐
โข Prokinetic agents segment accounted for noteworthy share in 2023, that is due to its ability to boost stomach muscles contractions and movement
โข Diabetic gastroparesis segment held the maximum share in 2023, owing to significant prevalence of diabetes due to change in people lifestyle and consumption patterns
โข Pharmacies segment will grow at highest pace during forecast period, that is attributed to significant expansion of retail pharmacy chains and easy accessibility to patients
โข North America dominated the global market in 2023, on account of rising prevalence of diabetes and presence of advanced healthcare infrastructure
๐๐ซ๐จ๐ฐ๐ฌ๐ ๐ฆ๐จ๐ซ๐ ๐๐๐ญ๐๐ข๐ฅ๐ฌ: @ https://www.polarismarketresearch.com/industry-analysis/gastroparesis-drugs-market
๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง ๐๐ฏ๐๐ซ๐ฏ๐ข๐๐ฐ:
๐๐๐ฌ๐ญ๐ซ๐จ๐ฉ๐๐ซ๐๐ฌ๐ข๐ฌ ๐๐ซ๐ฎ๐ ๐ฌ ๐๐๐ซ๐ค๐๐ญ:
โข Prokinetic Agents
โข Antiemetic Agents
โข Botulinum Toxin Injections
๐๐ฒ ๐๐ข๐ฌ๐๐๐ฌ๐ ๐๐ฅ๐๐ฌ๐ฌ:
โข Diabetic Gastroparesis
โข Idiopathic Gastroparesis
โข Post-surgical Gastroparesis
โข Others
๐๐จ๐ซ๐ ๐๐ซ๐๐ง๐๐ข๐ง๐ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ ๐๐ฒ ๐๐จ๐ฅ๐๐ซ๐ข๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก:
Human Growth Hormone Market: https://www.openpr.com/news/3439952/human-growth-hormone-market-share-trend-analysis-is-expected
Mental Health Screening Market: https://www.openpr.com/news/3440370/mental-health-screening-market-poised-for-usd-2379-05-million
Central Lab Market: https://www.openpr.com/news/3441880/central-lab-market-envisioned-at-usd-5-55-billion-by-2032-with
Analytical Standards Market: https://www.openpr.com/news/3442124/analytical-standards-market-size-and-share-analysis-is-expected
๐๐ผ๐ป๐๐ฎ๐ฐ๐ ๐จ๐:
Polaris Market Research
Email: sales@polarismarketresearch.com
Ph: +1-929 297-9727
๐๐ฏ๐ผ๐๐ ๐จ๐:
Polaris Market Research is a worldwide market research and consulting organization.
We give unmatched nature of offering to our customers present all around the globe across industry verticals.
Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.
We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gastroparesis Drugs Market Anticipated to Reach US$ 6,662.35 Million, with a CAGR of 4.4% from 2024 to 2032 here
News-ID: 3449140 • Views: โฆ
More Releases from Polaris Market Research & Consulting
Water Softening Systems Market to Reach USD 5.79 Billion by 2032, With a CAGR of โฆ
๐๐๐ญ๐๐ซ ๐๐จ๐๐ญ๐๐ง๐ข๐ง๐ ๐๐ฒ๐ฌ๐ญ๐๐ฆ๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ, ๐๐ข๐ณ๐ ๐๐๐ฏ๐๐ง๐ฎ๐, ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค, ๐๐ฏ๐๐ซ๐ฏ๐ข๐๐ฐ, ๐๐ง๐ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ. ๐๐ก๐ ๐ ๐ฅ๐จ๐๐๐ฅ ๐ฐ๐๐ญ๐๐ซ ๐ฌ๐จ๐๐ญ๐๐ง๐ข๐ง๐ ๐ฌ๐ฒ๐ฌ๐ญ๐๐ฆ๐ฌ ๐ฆ๐๐ซ๐ค๐๐ญ ๐ฐ๐๐ฌ ๐๐ฌ๐ญ๐ข๐ฆ๐๐ญ๐๐ ๐ญ๐จ ๐๐ ๐ฐ๐จ๐ซ๐ญ๐ก ๐๐๐ 3.36 ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง 2023 ๐๐ง๐ ๐ข๐ฌ ๐ฉ๐ซ๐๐๐ข๐๐ญ๐๐ ๐ญ๐จ ๐๐ฑ๐ฉ๐๐ง๐ ๐ญ๐จ ๐๐๐ 5.79 ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐๐ฒ 2032, ๐ฐ๐ข๐ญ๐ก ๐ ๐๐๐๐ ๐จ๐ 6.30% ๐๐ฎ๐ซ๐ข๐ง๐ ๐ญ๐ก๐ ๐๐จ๐ซ๐๐๐๐ฌ๐ญ ๐ฉ๐๐ซ๐ข๐จ๐ 2024 ๐ญ๐จ 2032.
๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐จ๐ฉ๐:
This report emphasizes overall sales volume, revenue, price, market share, and key companies to present a thorough overview ofโฆ
Camping Furniture Market Is Likely to Grow at a CAGR of 5.50% through 2032, Reac โฆ
๐๐ก๐ ๐๐๐ฆ๐ฉ๐ข๐ง๐ ๐๐ฎ๐ซ๐ง๐ข๐ญ๐ฎ๐ซ๐ ๐ฆ๐๐ซ๐ค๐๐ญ ๐ฌ๐ข๐ณ๐ ๐ข๐ฌ ๐ฉ๐ซ๐จ๐ฃ๐๐๐ญ๐๐ ๐ญ๐จ ๐๐ ๐ฏ๐๐ฅ๐ฎ๐๐ ๐๐ญ ๐๐๐ 250.65 ๐ฆ๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง 2023 ๐๐ง๐ ๐ข๐ฌ ๐๐ฑ๐ฉ๐๐๐ญ๐๐ ๐ญ๐จ ๐ซ๐ข๐ฌ๐ ๐ญ๐จ ๐๐๐ 405.83 ๐ฆ๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐๐ฒ 2032. ๐๐ก๐ ๐ฆ๐๐ซ๐ค๐๐ญ ๐ข๐ฌ ๐๐ฑ๐ฉ๐๐๐ญ๐๐ ๐ญ๐จ ๐ซ๐๐ ๐ข๐ฌ๐ญ๐๐ซ ๐ ๐๐๐๐ ๐จ๐ 5.50% ๐๐ฎ๐ซ๐ข๐ง๐ ๐ญ๐ก๐ ๐๐จ๐ซ๐๐๐๐ฌ๐ญ ๐ฉ๐๐ซ๐ข๐จ๐.
Various factors propelling the demand for camping furniture include:
โ The availability of a wide variety of advanced product designs, such as comfortable and multipurpose tables and seats, has increasedโฆ
Rope Market is expected to grow to USD 25.32 billion by 2032 | Polaris Market Re โฆ
Rope Industry - Market Insights, Size Revenue, Outlook, Overview, and Analysis. The global rope market was valued at USD 14.57 billion in 2023. It is expected to grow to USD 25.32 billion by 2032, expanding at a compound annual growth rate (CAGR) of 6.30% during the forecast period from 2024 to 2032.ย
๐น๐๐๐๐๐ ๐บ๐๐๐๐:
The research report sheds light on all the major industry aspects, including market size, share, revenue, and overallโฆ
Car Detailing Services Market Projected to Hit USD 62.93 Billion by 2032, to gro โฆ
According to the research report, the global Car Detailing Services Market was valued at USD 37.40 billion in 2022 and is expected to reach USD 62.93 billion by 2032, to grow at a CAGR of 5.4% during the forecast period.
๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐
๐จ๐ซ ๐
๐ซ๐๐ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐๐ฉ๐จ๐ซ๐ญ: https://www.polarismarketresearch.com/industry-analysis/car-detailing-services-market/request-for-sample
๐๐๐ซ๐ค๐๐ญ ๐๐ฏ๐๐ซ๐ฏ๐ข๐๐ฐ:
Car detailing is the process of improving a vehicle's interior and exterior look. A complete cleaning is possible; any enhancements to address minor flaws,โฆ
More Releases for Gastroparesis
Gastroparesis Drugs Market Analysis by 2020-2025
Scope of the Report:
The worldwide market for Gastroparesis Drugs is expected to grow at a CAGR of roughly x% over the next five years, will reach x million US$ in 2024, from x million US$ in 2019, according to a new Global Info Research study.
The report presents the market outlook for the Indian Phospho Gypsum product from the year 2019 to the year 2025. The report provides a definition of the product.โฆ
Gastroparesis Drugs Market - Use of Gastroparesis Drugs Is Highest In North Amer โฆ
The Gastroparesis Drugs Market is projected to reach $ 6,448.6 billion, an average annual rate of 4.7% from 2017 to 2023.
Gastric paralysis affects the normal spontaneous movement of the gastrointestinal muscles and interferes with normal digestion, causing problems related to nausea, vomiting and blood sugar levels and nutrition. Gastroparesis can be caused by diabetes or after surgery. Recently, advanced drugs such as metoclopramide, erythromycin, and anti-vomiting have been developed toโฆ
Diabetic Gastroparesis-Pipeline Review H1 2017
ReportsWeb.com has announced the addition of the โDiabetic Gastroparesis-Pipeline Review H1 2017โ this report provides an overview of the Diabetic Gastroparesis-Pipeline landscape.
ย Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Gastroparesis - Pipeline Review, H1 2017, provides an overview of the Diabetic Gastroparesis (Gastrointestinal) pipeline landscape.
Gastroparesis is a long-term complication of diabetes that involves the stomach and affects digestion. Prolonged high blood sugar levels can damage nerves in many partsโฆ
Diabetic Gastroparesis - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Diabetic Gastroparesis - Pipeline Review, H2 2017 to its growing collection of premium market research reports.
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Gastroparesis - Pipeline Review, H2 2017, provides an overview of the Diabetic Gastroparesis (Gastrointestinal) pipeline landscape.
Gastroparesis is a long-term complication of diabetes that involves the stomach and affects digestion. Prolonged high blood sugar levelsโฆ
Gastroparesis Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, Gastroparesis Global Clinical Trials Review, H2, 2017" provides an overview of Gastroparesis clinical trials scenario. This report provides top line data relating to the clinical trials on Gastroparesis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points statusโฆ
Diabetic Gastroparesis - Pipeline Market Research Report, 2017
Market Research Hub (MRH) has recently publicized a new study to its vast repository, which is titled as โDiabetic Gastroparesis - Pipeline Insight, 2017โ.ย This report provides comprehensive insights about pipeline drugs across this Diabetic Gastroparesis. The key objective of the report is to establish the understanding for all the pipeline drugs that are undergoing research across Diabetic Gastroparesis.
Request For Sample Report@ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1214082
This report provides information on the therapeutic development forโฆ